David KOFFI

Dr. David KOFFI

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2015 in Malaria Journal
Verified
Journal Article
Open access
PDF file
DKDavid KOFFI
David KOFFI
OTOffianan Andre Offianan TOURE
Offianan Andre Offianan TOURE
MVMarie-Louise Varela
Marie-Louise Varela
VIVIGAN-WOMAS Ines
VIGAN-WOMAS Ines
SBSylvain Béourou
Sylvain Béourou
RPRonald Perraut
Ronald Perraut
Advances in malaria control have reduced the burden of disease resulting from exposure to parasite infections. The consequences on naturally acquired immunity are unclear. A magnetic bead-based immunoassay (MBA) to assess antibody levels in populations living in endemic areas was previously evaluated. In this study, the effect of clinical attacks on immunity was analysed in three sentinel sites of Ivory Coast. Recombinant proteins or peptides derived from liver or blood stage antigens of Plasmodium falciparum (CSP, LSA141, LSA3, SALSA, PF13-DBL1α1, GLURP, AMA1, MSP1p19, MSP4p20), the CSP of Plasmodium malariae and the salivary glands antigen of Anopheles gambiae (gSG6) were covalently linked to a colour-coded microsphere (Luminex™ beads) for the multiplex assay. ELISA was used for whole parasite extract antigen. Blood samples (n = 94) of patients consulting for symptomatic malaria attacks and living in three different malaria endemic settings (rural and periurban) were analysed. Highly variable seroprevalence of antibody responses against parasite antigens was found ranging from 3 (gSG6) to 97 % (MSP4p20). A marked prevalence and significantly higher level of antibodies was found in patients from the rural site (Korhogo), those harbouring the lowest level of parasitaemia. The use of whole schizont extract could not discriminate immunity level, contrary to parasite-derived recombinant proteins or peptides. Prevalence of responders to LSA141 and levels of antibodies to PF13 were significantly different between the three settings. Moreover, the post-treatment clearance of parasites was clearly associated with a significantly higher level of antibody response for almost 50 % of the parasite antigens tested. The multiplex MBA-Magpix technology assay provides an accurate high throughput monitoring of parasite-specific antibodies during symptomatic malaria. The levels of antibody responses may provide a risk criterion with respect to the degree of parasitic infection. Additionally, they can be used as an indicator in the implementation of malaria prevention and local control strategies.

1 March 2021 in Journal of Medical Mycology
Verified
Journal Article
Closed access
DKDavid KOFFI
David KOFFI
IBI.V. Bonouman
I.V. Bonouman
ATA.O. Toure
A.O. Toure
FKF. Kouadjo
F. Kouadjo
MNM.R.E. N’gOu
M.R.E. N’gOu
DDD.W. Denning
D.W. Denning

20 November 2014 in Parasites & Vectors
Verified
Journal Article
Open access
PDF file
OTOffianan Andre Offianan TOURE
Offianan Andre Offianan TOURE
PKPenali L Kone
Penali L Kone
MCM’Lanhoro Aa Coulibaly
M’Lanhoro Aa Coulibaly
BABerenger Aa Ako
Berenger Aa Ako
EGEric A Gbessi
Eric A Gbessi
EBErnestine M Bokossa
Ernestine M Bokossa
The World Health Organization (WHO) recommends for sub-Saharan Africa a package of prompt and effective case-management combined with the delivery of insecticide-treated nets (ITN) and intermittent preventive treatment during pregnancy (IPTp) with sulphadoxine-pyrimethamine (SP) through the national antenatal care (ANC) programs. Implemented in Côte d’Ivoire around 2005, few Data on IPTp coverage and efficacy in the country are available. A multicentre, cross-sectional survey was conducted in Côte d’Ivoire from September 2009 to May 2010 at six urban and rural antenatal clinics. IPTp-sp coverage, Socio-economic and obstetrical data of mothers and neonate birth weights were documented. Peripheral blood as well as placental and cord blood were used to prepare thick and thin blood films. In addition, pieces of placental tissues were used to prepare impression smears and maternal haemoglobin concentration was measured. Regression logistics were used to study factors associated with placental malaria and LBW (<2.500 grams). A total of 1317 delivered women were enrolled with a median age of 26 years. A proportion of 43.28% of the women had received at least two doses of IPTsp during the current pregnancy although a high proportion (90.4%) of women received antenatal care and made enough visits (≥ 2). Variability in the results was observed depending on the type of area (rural/urban). Plasmodium falciparum was detected in the peripheral blood of 97 women (7.3%) and in the placenta of 119 women (9%). LBW infants were born to 18.8% (22/107) of women with placental malaria and 8.5% (103/1097) of women without placental malaria. LBW was associated with placental malaria. This study found relative low coverage of IPTp in the study areas which supported findings that high ANC attendance does not guarantee high IPTp coverage. Urgent efforts are required to improve service delivery of this important intervention.

17 July 2026 in Parasites & Vectors
Verified
Journal Article
Open access
PDF file
DKDavid KOFFI
David KOFFI
NTNicolas Tchitchek
Nicolas Tchitchek
FHFabien Herbert
Fabien Herbert
LTLandry Tiacoh
Landry Tiacoh
ATAndré Offianan Touré
André Offianan Touré
SPSylviane Pied
Sylviane Pied
Background: Naturally acquired immunity to Plasmodium falciparum involves parasite-specific antibodies as well as autoreactive responses that may contribute to immune regulation and tolerance. Characterizing these antibody repertoires across clinical phenotypes and transmission settings may help distinguish asymptomatic carriage from clinical malaria and identify biomarkers of exposure and protection. Methods: We conducted a cross-sectional study in three malaria-endemic settings in Côte d’Ivoire (Korhogo, Man, and Abobo). Individuals with mild malaria (MM; n = 94) were enrolled across all three sites, whereas asymptomatic carriers (AS; n = 33) and endemic controls (EC; n = 39) were enrolled in Abobo only. Total IgG responses to P. falciparum (3D7 whole-parasite extract), self-antigens (human brain extract), and mosquito exposure (gSG6-P1) were measured by ELISA or Luminex. The breadth and specificity of autoreactive IgGs were assessed by PANAMA blotting followed by mass spectrometry. Multivariate analyses were used to identify antigenic signatures associated with clinical phenotype and, among MM individuals, differences in transmission intensity. Results: Compared with MM, AS individuals exhibited lower total IgG reactivity to P. falciparum antigens but higher levels of autoreactive IgG3 with a broader antigenic repertoire. Proteomic analysis identified γ- and β-actin, as well as several metabolic enzymes (including succinate-CoA ligase, acetyl-CoA acyltransferase 2, acyl-CoA dehydrogenase, and glutaryl-CoA dehydrogenase) as targets distinguishing AS and EC from MM. Among MM cases, a cluster of brain antigens in the 50–75 kDa range differentiated sites with distinct transmission intensities. IgG responses to gSG6-P1 correlated with autoreactive IgG levels, suggesting an association between mosquito exposure and autoreactive immune responses. Conclusions: Asymptomatic P. falciparum infection in a high-transmission setting was associated with enhanced autoreactive IgG3 responses, a profile that may reflect clinical tolerance and cumulative exposure. Autoreactive antibody signatures, together with markers of mosquito exposure, may serve as candidate biomarkers of malaria exposure and naturally acquired immunity and could inform surveillance and control strategies in endemic areas.